207 related articles for article (PubMed ID: 15955412)
21. Mutational scanning of the human serotonin transporter reveals fast translocating serotonin transporter mutants.
Kristensen AS; Larsen MB; Johnsen LB; Wiborg O
Eur J Neurosci; 2004 Mar; 19(6):1513-23. PubMed ID: 15066148
[TBL] [Abstract][Full Text] [Related]
22. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.
Barker EL; Blakely RD
Mol Pharmacol; 1996 Oct; 50(4):957-65. PubMed ID: 8863842
[TBL] [Abstract][Full Text] [Related]
23. Serotonin transporter mutations associated with obsessive-compulsive disorder and phosphorylation alter binding affinity for inhibitors.
Zhang YW; Rudnick G
Neuropharmacology; 2005 Nov; 49(6):791-7. PubMed ID: 16112691
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor.
Horschitz S; Hummerich R; Schloss P
Neuroreport; 2001 Jul; 12(10):2181-4. PubMed ID: 11447330
[TBL] [Abstract][Full Text] [Related]
25. Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.
Larsen MB; Sonders MS; Mortensen OV; Larson GA; Zahniser NR; Amara SG
J Neurosci; 2011 Apr; 31(17):6605-15. PubMed ID: 21525301
[TBL] [Abstract][Full Text] [Related]
26. An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant.
Zhong H; Hansen KB; Boyle NJ; Han K; Muske G; Huang X; Egebjerg J; Sánchez C
Neurosci Lett; 2009 Oct; 462(3):207-12. PubMed ID: 19616061
[TBL] [Abstract][Full Text] [Related]
27. A cocaine insensitive chimeric insect serotonin transporter reveals domains critical for cocaine interaction.
Sandhu SK; Ross LS; Gill SS
Eur J Biochem; 2002 Aug; 269(16):3934-44. PubMed ID: 12180970
[TBL] [Abstract][Full Text] [Related]
28. [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
Synapse; 2003 Feb; 47(2):123-33. PubMed ID: 12454950
[TBL] [Abstract][Full Text] [Related]
29. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
Henry LK; Field JR; Adkins EM; Parnas ML; Vaughan RA; Zou MF; Newman AH; Blakely RD
J Biol Chem; 2006 Jan; 281(4):2012-23. PubMed ID: 16272152
[TBL] [Abstract][Full Text] [Related]
30. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
[TBL] [Abstract][Full Text] [Related]
31. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
[TBL] [Abstract][Full Text] [Related]
32. Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters.
Andersen J; Stuhr-Hansen N; Zachariassen L; Toubro S; Hansen SM; Eildal JN; Bond AD; Bøgesø KP; Bang-Andersen B; Kristensen AS; Strømgaard K
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12137-42. PubMed ID: 21730142
[TBL] [Abstract][Full Text] [Related]
33. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.
Zhong H; Haddjeri N; Sánchez C
Psychopharmacology (Berl); 2012 Jan; 219(1):1-13. PubMed ID: 21901317
[TBL] [Abstract][Full Text] [Related]
34. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
[TBL] [Abstract][Full Text] [Related]
35. The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram.
Sánchez C
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):91-5. PubMed ID: 16918708
[TBL] [Abstract][Full Text] [Related]
36. Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice.
David DJ; Froger N; Guiard B; Przybylski C; Jego G; Boni C; Hunt SP; De Felipe C; Hamon M; Jacquot C; Gardier AM; Lanfumey L
Eur J Pharmacol; 2004 May; 492(1):41-8. PubMed ID: 15145704
[TBL] [Abstract][Full Text] [Related]
37. Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter.
Plenge P; Shi L; Beuming T; Te J; Newman AH; Weinstein H; Gether U; Loland CJ
J Biol Chem; 2012 Nov; 287(47):39316-26. PubMed ID: 23007398
[TBL] [Abstract][Full Text] [Related]
38. Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain.
Hirano K; Seki T; Sakai N; Kato Y; Hashimoto H; Uchida S; Yamada S
Brain Res; 2005 Aug; 1053(1-2):154-61. PubMed ID: 16051196
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter.
Nandi A; Dersch CM; Kulshrestha M; Ananthan S; Rothman RB
Synapse; 2004 Sep; 53(3):176-83. PubMed ID: 15236350
[TBL] [Abstract][Full Text] [Related]
40. Identification of an allosteric modulator of the serotonin transporter with novel mechanism of action.
Kortagere S; Fontana AC; Rose DR; Mortensen OV
Neuropharmacology; 2013 Sep; 72():282-90. PubMed ID: 23632081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
